SCNI
Scinai Immunotherapeutics
$0.52
−$0.02 (−3%)Oct 29, 2026
Key metrics
The numbers that frame SCNI today
- Market cap
- $295.27K
- Gross margin
- -252.3%
- EV / Sales
- 0.7
- ROIC
- -13.8%
- Div yield
- 0%
- Debt / equity
- 0.3
- 52wk Low
- $0.50
- 52wk High
- $15.50
Growth
Revenue and earnings trend for SCNI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SCNI
Is Scinai Immunotherapeutics a good buy?
No. Scinai Immunotherapeutics has poor quality and poor momentum. Both signals point to a weaker setup. We think Scinai Immunotherapeutics is selling at a very high price.
What is the market capitalization of SCNI?
Scinai Immunotherapeutics's market capitalization is $295.27K.
What is the 52-week high for SCNI stock?
The 52-week high for Scinai Immunotherapeutics is $15.50. The current close of $0.52 is 96.7% below that high.
What is the 52-week low for SCNI stock?
The 52-week low for Scinai Immunotherapeutics is $0.50. The current close of $0.52 is 3% above that low.
Does SCNI stock pay dividends?
Scinai Immunotherapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SCNI?
Scinai Immunotherapeutics's Debt / Equity ratio is 0.31.